Clinical Trials on Malignant Melanoma in Switzerland
Total 191 results
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
Hoffmann-La RocheCompletedA Pharmacokinetic and Metabolism Study of 14C-labeled RO5185426 on Patients With Metastatic MelanomaMalignant MelanomaSwitzerland
-
Markus JoergerRecruiting
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
Cytos Biotechnology AGCompletedMalignant MelanomaSwitzerland
-
Centre Hospitalier Universitaire VaudoisRecruitingMetastasis From Malignant Melanoma of Skin (Diagnosis)Switzerland
-
Hoffmann-La RocheCompletedMalignant MelanomaSwitzerland
-
sigma-tau i.f.r. S.p.A.CompletedMalignant MelanomaFrance, Germany, Hungary, Italy, Poland, Portugal, Spain, Switzerland
-
University Hospital, Basel, SwitzerlandAnaveon AGRecruiting
-
Centre Hospitalier Universitaire VaudoisCompletedOcular MelanomaSwitzerland
-
University of ZurichCompleted
-
University Hospital Inselspital, BerneCompletedMerkel Cell Carcinoma | Malignant MelanomaSwitzerland
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, United Kingdom, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand, United Kingdom
-
Centre Hospitalier Universitaire VaudoisActive, not recruitingMetastatic MelanomaSwitzerland
-
Hoffmann-La RocheCompletedMalignant MelanomaFrance, Germany, Italy, Sweden, United States, Australia, Canada, United Kingdom, Netherlands, Switzerland, New Zealand, Israel
-
Swiss Group for Clinical Cancer ResearchCompletedMelanoma (Skin)Switzerland
-
Prof. Serge LeyvrazCompleted
-
Hoffmann-La RocheCompletedMalignant MelanomaCanada, Spain, United Kingdom, Hungary, Australia, Austria, Belgium, Ecuador, Estonia, Finland, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Portugal, Slovenia, Sweden, Turkey, Brazil, India, Germany, Bosnia and Herzegovina and more
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Spain, Hungary, Israel, United Kingdom, Australia, Austria, Belgium, Czechia, France, Germany, Italy, Netherlands, Russian Federation, Sweden, Switzerland, Canada, New Zealand, Norway
-
University Hospital, GenevaSuspendedStage IB Skin Melanoma | Stages III Skin Melanoma | Stages II Skin MelanomaSwitzerland
-
University of ZurichCompletedMelanoma Stage III or IV | No Prior ChemotherapySwitzerland
-
Centre Hospitalier Universitaire VaudoisActive, not recruitingMetastatic Melanoma Naive to Immune Therapy in Metastatic SettingSwitzerland
-
AmgenNo longer availableUnresected Stage IIIB to IVM1c MelanomaSwitzerland
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingMalignant MelanomaUnited States, Australia, Austria, Brazil, Canada, Chile, China, France, Germany, Israel, Italy, Korea, Republic of, Poland, South Africa, Spain, Sweden, Switzerland, United Kingdom
-
University Hospital, Basel, SwitzerlandGMP network of BaselCompletedAdvanced MelanomaSwitzerland
-
NovartisCompletedMetastatic MelanomaSwitzerland
-
University Hospital, Basel, SwitzerlandCompleted
-
Prof. Dr. Silke GillessenTerminated
-
University of Lausanne HospitalsFond'action contre le cancer; Barletta Foundation; NCCR (National Center of Competence...Suspended
-
University of ZurichCompleted
-
John O. PriorTerminated
-
Centre Hospitalier Universitaire VaudoisImmutep S.A.S.Terminated
-
Centre Hospitalier Universitaire VaudoisLudwig Institute for Cancer ResearchCompleted
-
Centre Hospitalier Universitaire VaudoisLudwig Institute for Cancer ResearchCompleted
-
University Hospital Inselspital, BerneCompleted
-
Philogen S.p.A.Eudax S.r.l.TerminatedMetastatic MelanomaSwitzerland, Italy, Austria, Germany
-
PfizerCompletedMelanoma | Unresectable Metatstatic Cutaneous MelanomaSwitzerland, Germany, France
-
Novartis PharmaceuticalsCompletedMetastatic MelanomaSwitzerland, United States
-
Centre Hospitalier Universitaire VaudoisCompleted
-
Institut CurieServier; UNICANCERCompletedUveal MelanomaFrance, Switzerland
-
EMD SeronoMerck KGaA, Darmstadt, GermanyCompletedN-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous MelanomaUnited States, Sweden, Australia, France, Italy, South Africa, Spain, United Kingdom, Germany, Netherlands, Israel, New Zealand, Belgium, Switzerland
-
University Hospital, Basel, SwitzerlandCompleted
-
OnxeoCompletedMelanomaAustria, France, Germany, Switzerland
-
Innovent Biologics (Suzhou) Co. Ltd.Innovent Biologics (USA), Inc.WithdrawnMetastatic Cutaneous Melanoma | Unresectable Cutaneous MelanomaUnited States, Germany, France, Australia, Spain, Switzerland, United Kingdom
-
European Organisation for Research and Treatment...Active, not recruitingCutaneous MelanomaFrance, Italy, Switzerland, Belgium, Netherlands, Germany, Poland, Slovenia, United Kingdom, Spain
-
Delcath Systems Inc.IQVIA BiotechCompletedMelanoma, OcularUnited States, Spain, Italy, Germany, United Kingdom, Switzerland, Belgium, Austria, France
-
European Organisation for Research and Treatment...CompletedMelanoma (Skin)France, Switzerland, Norway, Belgium, United Kingdom, Germany, Austria, Portugal, Italy
-
European Organisation for Research and Treatment...TerminatedMetastatic Cancer | Intraocular MelanomaSwitzerland, Italy, United Kingdom, Poland
-
Pierre Fabre Pharma GmbHPierre Fabre Pharma Austria; Pierre Fabre Pharma AGRecruitingMelanoma Stage IV | Melanoma Stage IIIAustria, Germany, Switzerland